Evidence map›Paper›PMID 34806794›Full record

ArticleHuman mutation2022

Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH).

Soodabeh Sarafrazi, Sean C Daugherty, Nicole Miller, Patrick Boada, Thomas O Carpenter, Lauren Chunn, Kariena Dill, Michael J Econs, Scott Eisenbeis, Erik A Imel and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Human mutation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Case Report: Deep intronicFrontiers in endocrinology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Diagnosis and Therapy of XLH.Calcified tissue international · 2025
    Review
  10. Review
  11. Article
  12. A deep intronicJBMR plus · 2025
    Article
  13. UnusualJBMR plus · 2025
    Article
  14. Article
  15. Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  16. Article
  17. Three exonic variants in theFrontiers in genetics · 2024
    Article
  18. Article
  19. Article
  20. Approach to Hypophosphatemic Rickets.The Journal of clinical endocrinology and metabolism · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Soodabeh SarafraziMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Sean C DaughertyMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Nicole MillerMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Patrick BoadaMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Thomas O CarpenterDepartment of Pediatrics (Endocrinology), Yale University School of Medicine, New Haven, Connecticut, USA.
Lauren ChunnData Science, Genomenon Inc., Ann Arbor, Michigan, USA.
Kariena DillMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.ORCID 0000-0002-9567-378X
Michael J EconsDivision of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Scott EisenbeisMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Erik A ImelDivision of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Britt JohnsonMedical Affairs, Invitae Corporation, San Francisco, California, USA.
Mark J KielData Science, Genomenon Inc., Ann Arbor, Michigan, USA.
Stan KrolczykMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Prameela RamesanMedical Affairs, Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Rebecca TrutyExternal Relations, Invitae Corporation, San Francisco, California, USA.
Yves SabbaghResearch and Development, Inozyme Pharma, Boston, Massachusetts, USA.
Ultragenyx Pharmaceutical (United States) · USCenter for Genomic Science · ITIndiana University School of MedicineInvitae (United States) · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-linked hypophosphatemia (XLH), the most common form of hereditary hypophosphatemia, is caused by disrupting variants in the PHEX gene, located on the X chromosome. XLH is inherited in an X-linked pattern with complete penetrance observed for both males and females. Patients experience lifelong symptoms resulting from chronic hypophosphatemia, including impaired bone mineralization, skeletal deformities, growth retardation, and diminished quality of life. This chronic condition requires life-long management with disease-specific therapies, which can improve patient outcomes especially when initiated early in life. To centralize and disseminate PHEX variant information, we have established a new PHEX gene locus-specific database, PHEX LSDB. As of April 30, 2021, 870 unique PHEX variants, compiled from an older database of PHEX variants, a comprehensive literature search, a sponsored genetic testing program, and XLH clinical trials, are represented in the PHEX LSDB. This resource is publicly available on an interactive, searchable website (https://www.rarediseasegenes.com/), which includes a table of variants and associated data, graphical/tabular outputs of genotype-phenotype analyses, and an online submission form for reporting new PHEX variants. The database will be updated regularly with new variants submitted on the website, identified in the published literature, or shared from genetic testing programs.

Indexed as

Databases, GeneticFamilial Hypophosphatemic RicketsGenetic Diseases, X-LinkedHypophosphatemiaPHEX Phosphate Regulating Neutral EndopeptidaseFemaleHumansMaleQuality of LifePHEX Phosphate Regulating Neutral EndopeptidasePHEX protein, humanfibroblast growth factor 23 (FGF23)locus-specific databaseosteomalaciaPhosphate regulating gene with Homology to Endopeptidases that maps to the X chromosome (PHEX)ricketsX-linked hypophosphatemia (XLH)

Identifiers

PMID34806794
PMCPMC9299612
OpenAlexW3216105001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.